Innovus Pharmaceuticals

• 

  Innovus Pharma Announces the Approval of its Product ProstaGorx in Canada for Benign Prostate Hyperplasia (“BPH”)

  5:07 PM | June 4, 2018

  ProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market:INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the approval by Health Canada of its product ProstaGorx as a Natural Health Product (NPN # 80085717) for

  Read more
• 

  Innovus Pharmaceuticals Announces the Closing of Its $3M Private Financing From Institutional Investors

  2:45 PM | August 1, 2016

  Company in a Strong Cash Position for Product Launches and Expedited Growth SAN DIEGO, CA– INNV, (Marketwired – Aug 1, 2016) – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company) www.innovuspharma.com (OTCQB: INNV), a company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases, announced today, the closing of its previously announced $3 million private financing from institutional investors. “Our ability to attract high caliber institutional investors into the Company

  Read more
• 

  Innovus Pharmaceuticals Eliminates Over $1.8M in Liabilities

  12:56 PM | June 15, 2016

  Company on Track to Be Being Cash Flow Positive Exiting 2016 SAN DIEGO, CA–INNV, (Marketwired – Jun 15, 2016) – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) www.innovuspharma.com (OTCQB: INNV), a company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases, announced today that the Company has reduced its debt obligation by $1.5 million and also eliminated approximately $300k in derivative liabilities as of 3/31/16, resulting in a total

  Read more
• 

  Innovus Pharmaceuticals Announces the Closing of the Acquisition of All of Beyond Human, LLCs Products Which Generated Over $2.2 Million in Sales in 2015

  4:06 PM | March 1, 2016

  Innovus Pharma’s Aggregate Annual Revenues Expected to Triple to Close to $4.0 Million SAN DIEGO, CA–INNV, (Marketwired – Mar 1, 2016) – Innovus Pharmaceuticals, Inc., (“Innovus Pharma” or the “Company) www.innovuspharma.com (OTCQB: INNV) a company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases, announced today the closing of the acquisition for substantially all of the assets of Beyond Human, for a cash purchase price of $630,000. In order to

  Read more

• 4/5 (LBYE.OB) Liberty Energy Launches Website From New Corporate Headquarters In Houston

  1:54 PM | April 5, 2010

  “The Company’s website provides a clear and reliable picture of the company’s development and exploration activities for our investors.”

  Read more